Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06295874
Other study ID # 12.10.2022/50
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 5, 2023
Est. completion date August 30, 2024

Study information

Verified date February 2024
Source Nigde Omer Halisdemir University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients in the intensive care unit (ICU) experience physical and psychological discomfort, including pain. Anxiety is a condition frequently encountered in the ICU. The hospital environment, especially the ICU, is reported as a significant cause of anxiety for patients. Comfort is a holistic, subjective and multidimensional concept that is affected by physical, environmental, social and psycho-spiritual contexts and changes over time and space. Comfort in intensive care is often associated with pain relief and end-of-life care. Assessment tools have been developed to measure patient comfort in the ICU, including levels of pain, delirium, and sedation. This work; Patients who are monitored in intensive care under high-flow and oxygen are treated with a mixture of lavender, thyme and eucalyptus oil (20 ml; lavender oil 5 drops, thyme oil 4 drops, eucalyptus oil 3 drops and 20 ml almond oil) twice a day for three days. This study was conducted to determine the effect of aromatherapy massage applied for a total of 30 minutes on some physiological parameters, pain, anxiety and intensive care comfort of the patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 61
Est. completion date August 30, 2024
Est. primary completion date August 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age and over, - Conscious patients, - Staying in intensive care for 24 hours or more, - Those with stable hemodynamic status, - Receiving O2 therapy, - Intubated patients, patients who have passed 24 hours after being extubated, - Those whose saturation level is 85 and above Exclusion Criteria: - Patients with peripheral neuropathy or quadriplegia, - Patients with open wounds on their body, - Patients receiving analgesia and sedation infusion, - Patients who are sedated, - Patients in delirium, - Patients with an allergy detected before starting the application, - Patients with a GKS (Glasgow Coma Scale) score of 3 and below

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level
The study applied a mixture of lavender, thyme and eucalyptus oil (5 drops of lavender oil, 4 drops of thyme oil, 3 drops of eucalyptus oil and 20 ml of almond oil in 20 ml) to patients who were monitored in intensive care on high-flow and oxygen, for three days. It was conducted as a randomized controlled single-blind study to evaluate the effects of aromatherapy massage applied twice a day for a total of 30 minutes on some physiological parameters, pain, anxiety and comfort levels.

Locations

Country Name City State
Turkey Ömer Halisdemir University Training and Research Hospital Nigde

Sponsors (1)

Lead Sponsor Collaborator
Nilgün Erdogan

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Other Drug Monitoring Form The medication monitoring form was created by the researcher, and the form will include the dosage of the analgesic and sedative medications the patient received in the intensive care unit during the study. The medication monitoring form will be recorded with the dosage taken before and after the application by the nurses who collect the data of the study. 2 years
Other Visual Pain Scale The scale developed by Price et al. (1983) is a scale in which patients evaluate their pain between 1 and 10. VAS is a scale used to describe varying degrees of pain experienced by a patient. It is evaluated at varying degrees between "0", "no pain" and "10", "severe pain". 2 years
Other Face Anxiety Scale The Facial Anxiety Scale was developed to determine the presence and level of patient anxiety based on facial expressions. The Facial Anxiety Scale, developed by McKinley and colleagues (2003), has been used in several studies for patients on invasive and non-invasive ventilation. Each item in the anxiety subscale is rated between 1 and 5 points, ranging from "not at all" to "extremely". 2 years
Other Comfort Rating Scale Numerik Konfor Derecelendirme Ölçegi, Kolcaba (2003) tarafindan gelistirilen (Kolcaba, 2003), 0'dan 10'a kadar degisen derecelerde kullanilan bir analog skaladir. Rahatlik 0-10 arasinda derecelendirilmektedir; 0, "hiç konfor yok", 10 "en yüksek konforu" göstermektedir. Hastanin durumuna göre degerlendirilmesi yapilmaktadir 2 years
Primary Patient Introduction Form The "Patient Introduction Form" prepared by the researcher based on the literature in order to obtain information about the characteristics of the patients who will form the sample includes questions such as the medical diagnosis of the patients, age, gender, chronic diseases, length of stay in intensive care, use of analgesics and sedative drugs. 2 years
Secondary Patient Follow-up Form The patient follow-up form was created by the researcher, and the follow-up results of physiological parameters throughout the study will be included in the form. Vital signs and oxygen saturation results of the patients before and after the application will be recorded on the patient follow-up form by the nurses who collect the data of the study. 2 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2